Honglin Hu
Chengdu, 610071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Impact of Huisheng Oral Solution Combined with Immune Checkpoint Inhibitors and Chemotherapy in Patients with Stage III-IV Non-Small Cell Lung Cancer: A Retrospective Analysis.
Journal: Journal of Cancer
Published: April 21, 2025
Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system.
Journal: Frontiers in pharmacology
Published: March 10, 2024
Deep learning analysis of histopathological images predicts immunotherapy prognosis and reveals tumour microenvironment features in non-small cell lung cancer.
Journal: British journal of cancer
Published: February 04, 2024
Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma.
Journal: Frontiers in cell and developmental biology
Published: December 06, 2020
Expression and clinical significance of CIP2A in small cell lung cancer patients
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: October 15, 2015
rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression.
Journal: Biochemical and biophysical research communications
Published: January 19, 2015
Role of SPHK1 regulates multi-drug resistance of small cell lung cancer and its clinical significance
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: November 19, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026